Log In
Print this Print this

imexon (Amplimexon)

  Manage Alerts
Collapse Summary General Information
Company AmpliMed Corp.
DescriptionSmall molecule cyanoaziridine
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPancreatic cancer
Indication DetailsTreat advanced stage IV metastatic pancreatic cancer in chemotherapy-naïve patients; Treat untreated advanced pancreatic adenocarcinoma
Regulatory Designation
PartnerHandok Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today